SAS and PERSOWN drive lifesaving insights to reduce COVID spread, improve global health
The partnership combines PERSOWN instant diagnostic
test data with SAS artificial intelligence and data visualization
software to help affordably prevent pandemics
CARY, N.C., and ATLANTA, Dec. 14, 2021
/PRNewswire/ -- Analytics leader SAS is partnering with medical
diagnostics and technology startup PERSOWN, formerly known as Blink
Science, to bring affordable, lifesaving technologies to the billions of
traditionally underserved people of the world. From visualizing disease
mutation and progression in the current COVID-19 pandemic to monitoring
treatment efficacy and compliance in clinical trials, the partnership will empower global health leaders, clinicians and researchers to make more informed decisions.
PERSOWN’s instant diagnostic test data combined with SAS’ analytics
software will help global health leaders better visualize, monitor and
manage COVID-19 variant outbreaks and prevent future pandemics.
PERSOWN endeavors to maximize global health with high-tech, low-cost medical diagnostics and health information technologies.
"At SAS, we know curiosity leads to innovation that helps move our world forward," said Steve Kearney,
PharmD, Medical Director at SAS. "Throughout the COVID-19 pandemic,
we've brought analytics to the front lines, helping better protect
vulnerable populations from the spread of the virus. Now we are working
together with PERSOWN to help prevent other pandemics and promote a
healthier future for us all."
PERSOWN is developing a novel point-of-care diagnostic platform that
plans to provide instant test results using ultra low-cost disposable
test strips and a handheld reader, fully integrated with a robust suite
of electronic health records applications. This platform will present a
cost-effective option for testing in parts of the globe where access to
sophisticated medical diagnostics
is scarce, potentially creating billions of integrated data points
across various disease states and among previously undiagnosed
populations.
With powerful SAS artificial intelligence,
visual analytic and data management software, PERSOWN will be able to
effectively mine diagnostic data to uncover infection trends and
visualize disease hot spots to better monitor and predict outbreaks.
These early insights will help governments and health organizations
implement practices that reduce disease spread, mitigate impact and
create early interventions.
"By using analytics and AI on data
gathered from PERSOWN diagnostics, public health officials and
researchers can identify patterns earlier and develop treatments or
policies to care for and protect their populations," said Eric Doherty,
President of PERSOWN. "We are proud to be partnering with the global
leader in analytics to help solve some of the world's health care
challenges."
About PERSOWN At
PERSOWN, we endeavor to maximize global health with high-tech, low-cost
medical diagnostics and health information technologies. Our goal is to
revolutionize point-of-care (POC) testing to ensure safe, fast, precise
diagnosis and treatment for acute and chronic conditions that impact
people throughout the world.
About SAS SAS
is the leader in analytics. Through innovative software and services,
SAS empowers and inspires customers around the world to transform data
into intelligence. SAS gives you THE POWER TO KNOW®.
BioFlorida is the voice of Florida's life sciences industry, representing 8,600 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 107,000 Floridians. Source: TEConomy/BIO (released 2022)
Print Page
Email to a Friend
